Management of imatinib-associated skin rash in a patient with metastatic gastrointestinal stromal tumor: a case report

由 Blay, Jean-Yves
出版 2012

Nilotinib: a Novel, Selective Tyrosine Kinase Inhibitor

由 Blay, Jean-Yves, von Mehren, Margaret
出版 2011

Accomplishments in 2008 in the Management of Gastrointestinal Stromal Tumors

由 Renouf, Daniel, Blay, Jean-Yves, Blanke, Charles
出版 2009

CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways

由 Voorzanger-Rousselot, Nathalie, Alberti, Laurent, Blay, Jean-Yves
出版 2006

Towards global consensus in the treatment of gastrointestinal stromal tumor

由 Reichardt, Peter, Blay, Jean-Yves, von Mehren, Margaret
發表在 Expert Rev Anticancer Ther (2010)

Perspective on Updated Treatment Guidelines for Patients With Gastrointestinal Stromal Tumors

由 Blay, Jean-Yves, von Mehren, Margaret, Blackstein, Martin E.
出版 2010

Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study

由 Assaad, Souad, Zrounba, Philippe, Cropet, Claire, Blay, Jean-Yves
發表在 Br J Cancer (2021)

Trabectedin and its potential in the treatment of soft tissue sarcoma

由 Cassier, Philippe A, Dufresne, Armelle, Blay, Jean-Yves, Fayette, Jérôme
出版 2008

Optimizing Tyrosine Kinase Inhibitor Therapy in Gastrointestinal Stromal Tumors: Exploring the Benefits of Continuous Kinase Suppression

由 Le Cesne, Axel, Blay, Jean-Yves, Reichardt, Peter, Joensuu, Heikki
出版 2013

From rare to well-done: importance of rare tumors in cancer therapeutic advances

由 Duffaud, Florence, Piperno-Neumann, Sophie, Penel, Nicolas, Blay, Jean-Yves
發表在 Oncotarget (2019)

Editorial: New Insights Into the Landscape of Rare Tumors: Translational and Clinical Research Perspective

由 De Vita, Alessandro, Bongiovanni, Alberto, Blay, Jean-Yves, Ibrahim, Toni
發表在 Front Oncol (2020)

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

由 Ménétrier-Caux, Christine, Ray-Coquard, Isabelle, Blay, Jean-Yves, Caux, Christophe
發表在 J Immunother Cancer (2019)

Metabolic landscapes in sarcomas

由 Miallot, Richard, Galland, Franck, Millet, Virginie, Blay, Jean-Yves, Naquet, Philippe
發表在 J Hematol Oncol (2021)

Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti–IL-6 Antibody

由 Gougelet, Angélique, Mansuy, Adeline, Blay, Jean-Yves, Alberti, Laurent, Vermot-Desroches, Claudine
出版 2009

The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines

由 Nishida, Toshirou, Blay, Jean-Yves, Hirota, Seiichi, Kitagawa, Yuko, Kang, Yoon-Koo
發表在 Gastric Cancer (2015)

Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma

由 Eberst, Lauriane, Cassier, Philippe A, Brahmi, Mehdi, Tirode, Franck, Blay, Jean-Yves
發表在 ESMO Open (2020)

Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al.

由 Assaad, Souad, Fuhrmann, Christine, Avrillon, Virginie, Ray-Coquard, Isabelle, Blay, Jean-Yves
發表在 Eur J Cancer (2020)

Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment

由 Ménétrier-Caux, Christine, Faget, Julien, Biota, Cathy, Gobert, Michael, Blay, Jean-Yves, Caux, Christophe
出版 2012

Giant-cell tumor of bone, anti-RANKL therapy

由 Dufresne, Armelle, Derbel, Olfa, Cassier, Philippe, Vaz, Gualter, Decouvelaere, Anne-Valérie, Blay, Jean-Yves
出版 2012

Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma

由 Bally, Olivia, Tassy, Louis, Richioud, Bertrand, Decouvelaere, Anne-Valérie, Blay, Jean-Yves, Derbel, Olfa
發表在 Clin Sarcoma Res (2015)